Vinod Khosla on machine learning and the Quantified Self

December 13, 2015

I talked with Vinod Khosla over the summer about machine learning and the Quantified Self.

Khosla was a founder of Sun Microsystems and is one of Silicon Valley’s most experienced investors in Quantified Self companies. His portfolio includes AliveCor, Ginger.io, Jawbone, Misfit, Narrative, and many other toolmakers that people doing QS projects will recognize. In our conversation, I ask Vinod about the role machine learning can realistically play in QS practices.

Below are links to three papers Vinod mentions in the interview:

Khosla, Vinod. “20-percent doctor included: Speculations & musings of a technology optimist.” (2014).

Beck, Andrew H., Ankur R. Sangoi, Samuel Leung, Robert J. Marinelli, Torsten O. Nielsen, Marc J. van de Vijver, Robert B. West, Matt van de Rijn, and Daphne Koller. “Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.” Science translational medicine 3, no. 108 (2011): 108ra113-108ra113.

Ioannidis, John PA. Why Most Published Research Findings Are False. PLoS Med 2, no. 8 (2005)

 

 

Related Posts

CGM Show&Tell June 13 2023

Gary Wolf

June 13, 2023

I talked with Vinod Khosla over the summer about machine learning and the Quantified Self. Khosla was a founder of Sun Microsystems and is one of Silicon Valley’s most experienced investors in Quantified Self companies. His portfolio includes AliveCor, Ginger.io, Jawbone, Misfit, Narrative, and many other toolmakers that people doing QS projects will recognize. In our...

New Show&Tell Event: Tracking Blood Glucose

Gary Wolf

May 31, 2023

Please join us for an hour of short "QS Show&Tell" talks about diet and metabolic discoveries using personal science. This session will focus on minimally invasive blood glucose monitor and meal and activity tracking with Nutrisense.

Astronauts

Gary Wolf

February 23, 2023

We The Scientists, a new book by Amy Dockser Marcus, tells the story of a group of families who force research attention on a rare disease